Isomorphic Labs is eyeing a $40B valuation: The Google DeepMind spinout led by Demis Hassabis is reportedly raising fresh funding for its AI-powered drug discovery.
The reported financing is a market signal about expectations for AI drug discovery, not evidence that a drug candidate has succeeded.